| P2093 | author name string | Jun Horiguchi | |
| | Sadayuki Hashioka | |
| | Rei Wake | |
| | Tsuyoshi Miyaoka | |
| | Maiko Hayashida | |
| | Michiharu Nagahama | |
| | Hiroyuki Miki | |
| P2860 | cites work | Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity | Q46484407 |
| | 7T T₂*-weighted magnetic resonance imaging reveals cortical phase differences between early- and late-onset Alzheimer's disease | Q48609900 |
| | Minocycline and fluorocitrate suppress spinal nociceptive signaling in intrathecal IL-1β-induced thermal hyperalgesic rats | Q48613201 |
| | Extensive brain pathology in a patient with aceruloplasminemia with a prolonged duration of illness | Q48920490 |
| | Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). | Q51899563 |
| | Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan | Q56441169 |
| | Studies in Desferrioxamine and Ferrioxamine Metabolism in Normal and Iron-Loaded Subjects | Q66921031 |
| | Increased plasma lipid peroxidation in patients with aceruloplasminemia | Q71297081 |
| | Selectivity of cation chelation to tetracyclines: Evidence for special conformation of calcium chelate | Q71804792 |
| | Free radicals and antioxidants in normal physiological functions and human disease | Q21710698 |
| | Aceruloplasminemia: molecular characterization of this disorder of iron metabolism | Q24564471 |
| | Ageing and Parkinson's disease: why is advancing age the biggest risk factor? | Q27021628 |
| | Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis | Q28270814 |
| | Astrocytes, but not microglia, are activated in oxaliplatin and bortezomib-induced peripheral neuropathy in the rat | Q28390312 |
| | Iron, brain ageing and neurodegenerative disorders | Q29615656 |
| | Oxidative stress and neurodegeneration: where are we now? | Q29617324 |
| | Genetic susceptibility in Parkinson's disease | Q30435626 |
| | Iron in chronic brain disorders: imaging and neurotherapeutic implications | Q31117154 |
| | Aceruloplasminaemia with progressive atrophy without brain iron overload: treatment with oral chelation | Q31131839 |
| | Ceruloplasmin metabolism and function | Q34132626 |
| | Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. | Q34603223 |
| | Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration | Q34690797 |
| | Clinical potential of minocycline for schizophrenia | Q34875176 |
| | Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis | Q35754529 |
| | Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE | Q35775365 |
| | Iron accumulation in Alzheimer disease is a source of redox-generated free radicals | Q36577461 |
| | A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window | Q36678875 |
| | Iron trafficking inside the brain | Q36978252 |
| | Does minocycline have antidepressant effect? | Q37082204 |
| | Minocycline and neurodegenerative diseases | Q37314674 |
| | Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA). | Q38065116 |
| | The neuropathology of neurodegeneration with brain iron accumulation | Q38161017 |
| | Altered brain metabolism of iron as a cause of neurodegenerative diseases? | Q40391355 |
| | Aceruloplasminemia, an inherited disorder of iron metabolism | Q42436733 |
| | Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family | Q42485956 |
| | Astrocytic deformity and globular structures are characteristic of the brains of patients with aceruloplasminemia | Q42528707 |
| | Minocycline inhibits neuronal death and glial activation induced by beta-amyloid peptide in rat hippocampus | Q45028409 |
| | Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation | Q46442849 |
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aceruloplasminemia | Q337604 |
| | minocycline | Q415336 |
| P304 | page(s) | e3594 | |
| P577 | publication date | 2016-05-01 | |
| P1433 | published in | Medicine | Q15716652 |
| P1476 | title | Aceruloplasminemia With Psychomotor Excitement and Neurological Sign Was Improved by Minocycline (Case Report) | |
| P478 | volume | 95 | |